Generation Bio Co. (GBIO) Financials

Stock symbol GBIO is outdated, potentially delisted? Maybe it is available on other exchange?

GBIO Assets vs Liabilities

Date	Assets	Liabilities
Sept. 30, 2025	121.9 million	71.3 million
June 30, 2025	179.4 million	125.3 million
March 31, 2025	201.3 million	128.0 million
Dec. 31, 2024	231.2 million	145.0 million

GBIO Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.

Date	Free Cash Flow	Stock based compensation
Sept. 30, 2025	-52.7 million	2.0 million
June 30, 2025	-17.3 million	1.7 million
March 31, 2025	-28.6 million	2.0 million
Dec. 31, 2024	-16.2 million	3.2 million

GBIO Net Income

No data available :(

GBIO Cash and Debt

Graph available only for paid members. Upgrade to see it.

Date	Cash	Debt	Capital Lease
Sept. 30, 2025	89.6 million	19.7 million	26.1 million
June 30, 2025	141.4 million	75.6 million	85.3 million
March 31, 2025	157.6 million	78.1 million	87.6 million
Dec. 31, 2024	185.2 million	80.6 million	93.6 million

GBIO Shares Outstanding

Graph available only for paid members. Upgrade to see it.

Date	Shares Outstanding
Sept. 30, 2025	6.7 million
June 30, 2025	6.7 million
March 31, 2025	6.7 million
Dec. 31, 2024	6.7 million

GBIO Expenses

Graph available only for paid members. Upgrade to see it.

Date	Capex	R&D	G&A	S&M
Sept. 30, 2025	-	21.6 million	12.2 million	-
June 30, 2025	459000	15.5 million	7.7 million	-
March 31, 2025	246000	15.4 million	8.8 million	-
Dec. 31, 2024	378000	15.5 million	8.7 million	-

GBIO Cost of Revenue

Graph available only for paid members. Upgrade to see it.

Date	Revenue	Cost of Revenue
Sept. 30, 2025	1.6 million	-
June 30, 2025	765000	-
March 31, 2025	8.7 million	-
Dec. 31, 2024	4.2 million	-

GBIO

Price: $5.34

52 week price:

3.00

8.43

Earnings Per Share: -9.37 USD

P/E Ratio: -0.60

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 16029

Market Capitalization: 38.0 million

Links:

GBIO on Yahoo Finance